Tonix Pharma (TNXP) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharma (NASDAQ: TNXP) reported Q3 EPS of ($3.59), in-line with the analyst estimate of ($3.59). Revenue for the quarter came in at $3.29 million versus the consensus estimate of $3.1 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
- SEI names Rob Wrzesniewski head of Stratos technology
- Webull launches SPV offering for accredited investors via Monark
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
